Rigel Pharmaceuticals, Inc.
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Each member of the Board of Directors (the “Board”) of Rigel Pharmaceuticals, Inc. (the “Company”) who is not also serving as an employee of the Company or any of its subsidiaries (each such member, an “Eligible Director”) will receive the compensation described in this Non-Employee Director Compensation Policy (this “Policy”). An Eligible Director may decline all or any portion of his or her compensation by giving notice to the Company prior to the date cash is to be paid or equity awards are to be granted, as the case may be. This Policy may be amended at any time in the sole discretion of the Board, or by the Compensation Committee of the Board at the recommendation of the Board.
Annual Cash Compensation
The annual cash compensation amount set forth below is payable to Eligible Directors in equal quarterly installments, payable in arrears on the last day of each fiscal quarter in which the service occurred. If an Eligible Director joins the Board or a committee of the Board at a time other than effective as of the first day of a fiscal quarter, each annual retainer set forth below will be pro-rated based on days served in the applicable fiscal year, with the pro-rated amount paid for the first fiscal quarter in which the Eligible Director provides the service, and regular full quarterly payments to be paid thereafter. All annual cash fees are vested upon payment.
|Annual Board Service Retainer:
|All Eligible Directors: $50,000
|Non-executive chairperson of the Board: $90,000 (inclusive of Annual Board Service Retainer)
|Annual Committee Member Service Retainer:
|Member of the Audit Committee: $12,000
|Member of the Compensation Committee: $10,000
|Member of the Nominating and Corporate Governance Committee: $10,000
|Member of the Finance Committee: $5,000
|Member of the Scientific and Clinical Trial Advisory Committee: $10,000
|Annual Committee Chair Service Retainer (inclusive of Committee Member Service Retainer):
|Chairperson of the Audit Committee: $22,000
|Chairperson of the Compensation Committee: $15,000
|Chairperson of the Nominating and Corporate Governance Committee: $15,000
|Chairperson of the Finance Committee: $10,000
|Chairperson of the Scientific and Clinical Trial Advisory Committee: $15,000
The Company will also reimburse each of the Eligible Directors for his or her travel expenses incurred in connection with his or her attendance at Board and committee meetings. Travel expenses include reasonable air and ground transportation, meals, and hotel. Eligible expenses incurred must be itemized and submitted for payment with receipts attached.
The equity compensation set forth below will be granted under the Company’s 2018 Equity Incentive Plan (as amended, the “Plan”), subject to the approval of the Plan by the Company’s stockholders. All stock options granted under this Policy will be non-statutory stock options, with an exercise price per share equal to 100% of the Fair Market Value (as defined in the Plan) of the underlying common stock on the date of grant, and a term of 10 years from the date of grant (subject to earlier termination in connection with a termination of service as provided in the Plan).